Italy ends Aspen pharma monitoring
Credit: Pipatc/iStock
Italy’s competition authority has ended its investigation into Aspen, concluding that the drugmaker has complied with price regulations imposed since its €5 million fine in 2016.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Subscribe now